Every fact traced to its source, and checked against it. Explore the companies, facts, and conclusions behind the news.
Conclusions our AI is drawing from the traced facts — read them as interpretation, each grounded in the data and the entities it names.
Enterprise software is shifting toward autonomous, AI-agent-driven products. SAP (Autonomous Enterprise, Joule), Meta (a new Enterprise Platform led by ex-MongoDB CEO Chirantan Desai) and UiPath (raised guidance) are pushing from the top. Meanwhile AI-security and governance startups are being acquired (Fortinet–Virtue AI, Harvey–Guardrails AI, Tiny–Oso Cloud) and seed-stage agent companies keep raising capital (Dextr, Latitude, Groq). Investors such as Norwest's Sean Jacobsohn see finance and ERP back-office software as the easier area to disrupt. Trust and enforced governance are treated as preconditions for regulated sectors like finance, and AI is judged unreliable for calculations.
A cluster of CEO successions, board appointments and governance enhancements (Verra Mobility, Mattel, Heineken, Brown-Forman, Xilam, interim-to-advisor handoffs) sits alongside restructuring and M&A events requiring board or shareholder approval (Chevron/Hess Midstream, onsemi/Synaptics, Kneat sale process, NGEx spin-out, Seibu capital allocation). The common thread is boards using orderly succession, independent committees and formal shareholder votes to manage transitions and capital reallocation. Little of it is AI-finance specific; the pattern is broad corporate-governance activity with a constructive, planned tone.
Sell-side coverage this period is dominated by AI-infrastructure plays: memory and chips (Micron, Sandisk, ASML), data centers (Digital Realty), dispatchable power (NuScale, Bloom Energy) and quantum computing (D-Wave). Analysts are bullish on these, with Digital Realty raising FFO guidance and a buy on SMR, but they flag stretched valuations (QBTS at 171x sales) and a sharp SpaceX drawdown of more than 40% from its highs. Consumer and restaurant names (Wendy's, Gap, Levi, Nike, Capital One) show a choppy, K-shaped economy, with weak traffic, slow recoveries and credit-reserve worries. Biotech catalysts (ivonescimab PDUFA, Iovance) and debt maturities add event-driven risk.
Finance leadership is changing hands (Rivian's CFO leaving for GE Vernova, new CFOs at Penguin Solutions and PJT Partners). At the same time CFOs and their advisers are preparing for agentic AI: PwC and SAP are extending their AI collaboration, SAP is showing its 'Autonomous Enterprise', Harvey is acquiring Guardrails AI, and Morgan Foods' CFO expects a shift from reactive to proactive finance work. Alongside this, regional banks are reporting improving net interest margins (3.99% vs 3.51% a year earlier), but they face deposit competition and the Durbin Amendment from mid-2027, while NIKE is cutting costs through its 'Pace' operating model.
Oncology is moving toward AI-designed biologics, personalized mRNA vaccines (Merck/Moderna's intismeran, with detailed data due at ESMO on Oct 24) and ADC-plus-bispecific combinations (Summit's ivonescimab with AstraZeneca/Daiichi's Datroway in first-line TNBC, BLA PDUFA date Nov 14). Large pharma is putting AI into discovery workflows, with AstraZeneca describing a 'lab of the future' and agentic de novo biologics design. Commercial results are also strong, with Novocure posting record revenue, Q2 oncology guidance narrowed and raised, and Kiniksa's Arcalyst revenue growing. Smaller names are more mixed: ADC Therapeutics is cutting its workforce to extend runway into 2028, and OPKO issued softer Q3 guidance.
AI is moving from hype to monetization and institutionalization: Micron's record results and stronger fiscal 2027 guidance (framed by its CEO around 'Super Intelligence') show hardware demand still accelerating, while Alphabet's bull case rests on converting AI engagement into revenue against heavy capex and legal pressure. In parallel, AI-focused startups are absorbing most jumbo venture funding, and the policy and governance layer is thickening, with agent-governance startups, Pentagon AI spending, content watermarking, border-surveillance scrutiny and university AI-literacy programs. Leadership churn (e.g., OpenAI's Lightcap) and new frontier-model launches such as Claude Opus 5.5 show a fast-moving, capital-intensive race.
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Samsung will likely announce a unified smart home AI platform or hub within 2-3 months that connects these disparate AI-enabled products
Sustained AI feature expansion across Samsung ecosystem in Q1-Q2 2026, with likely follow-up announcements for mobile devices and additional appliances
NVIDIA GPU acceleration is becoming the dominant infrastructure for AI chip design and EDA workflows, creating a self-reinforcing ecosystem where AI chips are designed using AI-accelerated tools
88% confidence · untestedData center infrastructure investments are shifting from traditional cloud providers to AI-specific facilities, with hyperscalers willing to commit $20B+ multi-year contracts for AI-optimized data center capacity, creating opportunities for specialized infrastructure developers
88% confidence · untestedLLM sycophancy is primarily caused by reinforcement learning from human feedback (RLHF) optimization for user approval rather than truthfulness, creating a systematic bias that degrades model reliability in extended conversations
85% confidence · untestedAI safety concerns are escalating as models gain access to classified and sensitive data, creating new security vulnerabilities and ethical challenges around training data governance
85% confidence · untestedHyperscaler AI infrastructure investments exceeding $200B combined will drive semiconductor demand and AI chip production capacity expansion in 2026
85% confidence · untestedOP Pohjola's Financial Statements Bulletin 1 January–31 December 2025: Another strong year for OP Pohjola – operating profit EUR 2,269 million
“OP Pohjola's Financial Statements Bulletin 1 January–31 December 2025: Another strong year for OP Pohjola – operating profit EUR 2,269 million OP Pohjola Financial Statements Bulletin Stock Exchange Release 11 February 2026 9.00 am EET OP Pohjola's Financial Statements Bulletin 1 January–31 December 2025: Another stron…”
Stock market today: Dow slips, Nasdaq pops as Amazon's OpenAI deal boosts AI bets
“Stock market today: Dow slips, Nasdaq pops as Amazon's OpenAI deal boosts AI bets US stocks turned mixed Monday morning as Wall Street looked to carry its momentum into the first trading session, with Big Tech names like Amazon (AMZN) and Nvidia (NVDA) again leading the way higher…”
ChannelCon 2026 Registration Opens: “The Channel Effect” to Take Center Stage in San Diego August 3–5
“ChannelCon 2026 Registration Opens: “The Channel Effect” to Take Center Stage in San Diego August 3–5 OAKBROOK TERRACE, Ill., March 25, 2026 (GLOBE NEWSWIRE) -- Registration is now open for ChannelCon 2026, the Global Technology Industry Association (GTIA)’s premier annual event, which will take place August 3–5, 2026,…”
$9.8 Billion in Autonomy Spending Hits the AI-Boosted Defense Supply Chain
“$9.8 Billion in Autonomy Spending Hits the AI-Boosted Defense Supply Chain NEW YORK, Feb…”
Vopak reports record financial results for 2025 and announces shareholder distributions program of around EUR 1.7 billion through year-end 2030
“Vopak reports record financial results for 2025 and announces shareholder distributions program of around EUR 1.7 billion through year-end 2030 The Netherlands, 25 February 2026 Vopak reports record financial results for 2025 and announces shareholder distributions program of around EUR 1.7 billion through year-end 203…”
Standard BioTools Announces Filing of Registration Statement in Connection with Treeline Biosciences Transaction
“Standard BioTools Announces Filing of Registration Statement in Connection with Treeline Biosciences Transaction Highlights combined company’s strong financial position with over $900 million expected at closing, Treeline’s deep clinical-stage pipeline, planned 2027 data updates for TLN-121 and TLN-372, and expected ne…”
Two different margin values (16% vs 18%) are recorded for the same entity (Shopify Inc.) at the identical timestamp (2026-08-05 00:00:00). With no distinguishing context (same period designation, no qualifier for margin type), these represent conflicting data about the same fact.
Fact B (Q1 2026) and Fact A (Q2 2026) are recorded as observed on the same date: 2026-03-29. This is temporally impossible, since Q2 2026 (April–June) has not yet occurred as of 2026-03-29 (mid-Q1). Financial results for a future period cannot be observed before that period ends. Additionally, 3.7 USD is implausibly low as a cash position for Qualcomm Incorporated, suggesting a data entry error in Fact B.
Both facts measure EPS for Citigroup with identical observation dates (2025-12-31). FACT A explicitly specifies FY 2025 annual EPS at 6.99 USD/share, while FACT B reports 1.65 USD with an unspecified fiscal period (N/A). The values differ by a factor of ~4.2x, which is too large to explain by rounding, methodology, or data quality variance. While FACT B's 'N/A' fiscal period introduces ambiguity about whether it represents the same annual period, both observations are timestamped identically and purport to measure the same metric on the same date. If both represent FY 2025 annual EPS, this is a direct value conflict. If FACT B represents a different period (e.g., quarterly, TTM, or interim), the ambiguous labeling still constitutes a data quality issue that obscures the reconciliation.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
Both facts measure the same attribute (cash) for the same entity (Tesla Inc.) at the same point in time (2025-12-31). Although labeled with different fiscal period categories (FY 2025 vs Q4 2025), both periods end on the same date, making them equivalent time snapshots. The values differ drastically: $16.513 billion vs $44.06 USD. Since Q4 2025 is the final quarter of FY 2025, both should report identical cash balances at period-end. A 375 million-fold magnitude difference indicates a real contradiction, likely caused by a data quality issue (unit error, miscategorization, or source error in FACT B).
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Every fact is traceable to the document it came from — see how we source every claim.
Two dated events will test oncology's new tools within weeks: Merck and Moderna's personalized mRNA vaccine data at ESMO on Oct. 24, and the FDA decision on Summit's ivonescimab on Nov. 14. We checked Merck's SEC-filed numbers and flag where the sources are weak.
Meta's new enterprise platform will be led by MongoDB's departing CEO, while small AI-native startups raise funding. Investors say back-office finance software is next, but one of them warns AI is bad at maths. We flag which sources are weaker and which parts of the story our evidence cannot yet support.
A survey says 100% of organizations plan to use AI agents within two years, yet only about 45% of company data is AI-accessible. We checked the claims against sources, and the survey's publisher scored poorly on reliability, so we flag that. Nvidia's SEC-verified costs show the build-out is real.
A personalised mRNA vaccine from Merck and Moderna stopped melanoma returning in a trial, and AstraZeneca is betting AI can speed up drug design. Via News checked what the record supports: some of the optimism rests on firm data, and some on sources that failed our own reliability tests.
Verified SEC figures show Nvidia's cost of revenue rose about 3.8 times in two fiscal years. A survey says every respondent plans to use AI agents, but company data and trust lag. That survey's source failed our check on all 11 claims we tested, so we flag it and lean on the data that held.
SEC-filed figures show Micron nearly doubled its capital spending in fiscal 2025 and now holds about 2.5 times the cash it had a year earlier. Analyst enthusiasm for power, data-center and quantum stocks rests on sources that held up only about half the time in our checks.
Companies from Manulife to Box customers are rolling out AI agents, and funding is flowing. But a trade-press study reports that in 'data laggard' firms, AI can reach 30% or less of company data. That source has a poor measured record, so we flag it as a claim, not a fact.
Every company surveyed by MIT Technology Review plans to use AI agents within two years, yet firms with weak data give those agents access to 30% or less of it. Only some of this is firmly established: that survey's source scores 0% on our reliability check, and the Nvidia figures are SEC-verified.
Adobe's weak guidance, Alphabet's negative free cash flow, and a wave of safety-driven departures from Anthropic, Google and OpenAI show investors and insiders both demanding proof, not promises — even as California moves first to regulate AI's reach into children's lives.
A single summit produced roughly $950 billion in AI infrastructure deals and locked Nvidia into South Korea's memory supply chain, while one research firm says Wall Street is still underpricing the memory chip boom behind it. Here's what's verified, what's just one analyst's call, and what's still speculative.
C3.ai's CEO sold $4.8 million in stock the same week the industry's biggest AI-agent-trust survey turned out unreliable on 11 checked claims, even as Manulife, Box and a wave of banking and healthcare startups commit real budgets. Via News separates the verified from the unverified.
Google now lets users strip visible watermarks from Gemini-made images, video and music — a move that cuts against the story of an industry rushing toward stronger AI-content labeling, and lands the same week OpenAI lost another senior executive.
Nvidia and South Korea's chipmakers signed roughly $950 billion in new AI agreements in July, including a deal to help secure Nvidia's HBM memory supply from SK Hynix, even as chip stocks logged a sharp correction and the Nasdaq 100 hit a 2.75-month low. Via News traces the deals, earnings and balance-sheet data behind the divergence.
A late-July selloff cut deep into AI-chip stocks — Micron fell nearly 40% from its peak — even as Nvidia expanded its SK hynix memory deal, GlobalFoundries signed a $300M federal photonics award, and Skyworks-Qorvo named a combined leadership team. The data show a maturing boom repricing risk, not a broken one.
Nearly all enterprises surveyed say they'll deploy AI agents within two years, but agents can typically reach under half of company data — and as little as 30% at 'data laggard' firms. Platform giants are selling governance; a new wave of startups is skipping the data problem by targeting narrow, auditable back-office tasks instead.
Brad Lightcap, OpenAI's special projects lead and the company's former chief operating officer, has announced his departure from the company.
Insurer Manulife, software firm Box and data platform Snowflake are each rolling out enterprise AI agent tools this year, spanning insurance, content management and data operations worldwide. A fintech startup, Casap, is building agents for dispute resolution, while enterprise leaders across regions report unclear governance for the technology.
Micron and SanDisk are among 2026's top-performing chip stocks on AI memory demand, but both have fallen sharply from June record highs. Figures dated and sourced.
Jeff Dean and Sanjay Ghemawat quit Google within the same week to launch startup Discovery Loop, while Demis Hassabis stepped back from running DeepMind. Alphabet responded by investing in the new venture rather than treating the exits as a pure loss, a hedging strategy now spreading across global AI markets.
Oriol Vinyals, co-leader of Google's Gemini models, has left to co-found Discovery Loop, a new frontier AI venture. The move puts a veteran of one of the world's best-funded AI labs into a startup that must build compute, capital and talent from scratch amid intense global competition.
Bloom Energy signed a $1.7 billion fuel-cell agreement with Nebius AI, one of the largest on-site power deals for AI data centers to date. The company also struck a deal with utility giant AEP and expanded distribution in South Korea, showing on-site generation is now a global bottleneck for AI buildout.
Bloom Energy signed three fuel-cell partnerships in quick succession, led by a $1.7 billion deal with Nebius AI, plus deals with US utility AEP and South Korea's SK Ecoplant and SK Eternix. Analysts say the geographic spread signals a global scramble for AI data center power beyond traditional grid capacity.
A cluster of AI-native drug discovery platforms launched worldwide in early-to-mid 2026, all running on NVIDIA GPU infrastructure. Novo Nordisk's decision to outsource cell therapy research to an AI-native partner signals a broader industry shift from in-house labs to external, GPU-powered specialists.
BlackRock priced a $12.5 billion bond tied to the Meta-BlackRock Texas Data Center Complex at a steep 7.53% yield after weak demand from investors worldwide. Credit-default swaps on major AI-linked firms jumped in tandem, signaling that credit markets globally are pricing AI infrastructure risk far more cautiously than equity markets.
KLA raised its 2026 wafer fabrication equipment forecast to the low-$150 billion range, citing AI chip demand. The California-based supplier also lifted quarterly revenue guidance to $4 billion and its advanced packaging target to $1.1 billion, alongside a 10-for-1 stock split.
Amkor Technology posted record second-quarter revenue as AI demand lifted chip packaging volumes, though weaker Q3 guidance points to uneven growth. Nvidia, the U.S. government, and chipmakers on three continents are all moving capital and consolidating to keep pace with AI infrastructure demand.
Every fact here is structured and source-traced — so AI systems inherit ground truth, not re-narrated claims. The same facts a person reads, a model can query.